ITMCTR2200005499尚未招募未知
Evaluation of Clinical Efficacy and Mechanism of Yanling Yishou Decoction on Intervention of Chronic Fatigue Syndrome with Deficiency of Heart and Spleen
Affiliated Hospital of Nanjing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 65（—）
- 性别
- All
入选标准
- •(1).Meet the CDC criteria, revised in 2003, for CFS.
- •(2).Meet the judgment standard of TCM diagnosis of deficiency of heart and spleen syndrome
- •(3).Age 18 to 65.
- •(4).A score of =35 on the Checklist Individual Strength Scale.
- •(5).Participant signed the informed consent form.
- •(6).Participant agreed to avoid other CFS medications during the trial.
排除标准
- •Participants who meet any of the following criteria will be excluded:
- •(1).Participant had limited physical function and cannot perform moderate exercise.
- •(2).Participant is currently pregnant or breastfeeding
- •(3).Participant had one of these following diseases that may cause chronic fatigue: a history of cancer, sleep apnea, narcolepsy, hepatitis B or C virus infection, anemia, tuberculosis, endocrine/metabolic diseases (diabetes, hyperthyroidism, hypothyroidism, severe obesity (body mass index (BMI) = 35), autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis).
- •(4).Participant had one of these following psychosocial diseases that may cause chronic fatigue: severe depression, anxiety neurosis, schizophrenia, bipolar disorder, alcohol or other forms of substance abuse.
- •(5).Participant had take one of these following drugs within the first 2 weeks: antidepressants, anxiolytics, sleeping pills or antihistamines.
- •(6).Participant will purchase or take vitamin or mineral supplements during this study period.
- •(7).Participant undertake too much workload (for example, undertake multiple tasks);
- •(8).Participant had a history of surgery within six months.
- •(9).Participant had accompanied by severe heart, kidney, lung, liver, brain diseases, or severe physical dysfunction. Clinical drug intervention are not available.
- •(10) Participant 's vital signs are not stable;
- •(11).Participant will have a frequent changes in the working environment or other situations that are likely to cause loss to follow-up.
- •(12).Participant had participated in other clinical trials at present.
研究者
相似试验
尚未招募
不适用
Evaluation of clinical efficacy and mechanism of Yunv Decoction in treating type 2 diabetes mellitus with syndrome of yin deficiency due to intense heatdiabetes mellitusITMCTR2200005821Guang'anmen Hospital of China Academy of Chinese Medical Sciences
已完成
不适用
Yoga package for diabetes managementCTRI/2020/12/029573SRI DHARMASTHALA MANJUNATHESHWARA COLLEGE OF AYURVEDA AND HOSPITAL HASSA42
尚未招募
1 期
Study on the Therapeutic Effect and Mechanism of Yinaokang on Post-stroke Cognitive Impairment No DementiaITMCTR2000004178GuangDong Provincial Hospital of Chinese Medicine
已完成
不适用
Exploratory study for the efficacy and safety of Yokukansankachimpihange on behavioral and psychological symptoms of dementia (BPSD) in patients with Alzheimer's disease (AD).AD patients with BPSDJPRN-UMIN000018369Keio University School of Medicine20
未知
Unknown
The exploratory study of Yokukansankachimpihange on BPSD in patients with DLB.JPRN-jRCT1080222763Tsumura & Co.20